Reducing the level of infiltration of Tregs cells that inhibit the proliferation of CD4+ T cells [65, 66] can effectively improve the OS of cancer patients [67], and a higher level of infiltration of resting DCs is correlated with low OS [68]. Here, CD4 is linked to cancer.